|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/18 | |
| A61P 3/10 |
| (11) | Number of the document | 3062881 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14857066.6 |
| Date of filing the European patent application | 2014-10-27 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/062378 |
| Date | 2014-10-27 |
| (87) | Number | WO 2015/065897 |
| Date | 2015-05-07 |
| (30) | Number | Date | Country code |
| 201361896473 P | 2013-10-28 | US | |
| 201361922586 P | 2013-12-31 | US | |
| 201462067273 P | 2014-10-22 | US |
| (72) |
LING, Lei, US
|
| (73) |
NGM Biopharmaceuticals, Inc.,
333 Oyster Point Blvd., South San Francisco CA 94080,
US
|
| (54) | CANCER MODELS AND ASSOCIATED METHODS |
| CANCER MODELS AND ASSOCIATED METHODS |